Stay updated with breaking news from Theragnostics Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Berlin, Germany, 4 April 2024 - Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and treatment of certain hard-to-treat cancers, today announces that it will be presenting a poster, demonstrating its new findings on the discovery of novel macrocyclic...
/PRNewswire/ -- Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and treatment of certain...
Ariceum Therapeutics files for UK Clinical Trial Authorisation (CTA) to test its First-in-Class Iodine-123 labelled PARP inhibitor in patients with recurrent glioblastoma
/PRNewswire/ -- Ariceum Therapeutics, a private biotech company developing radiopharmaceutical products for the diagnosis and treatment of certain...
Ariceum Therapeutics Expands Pipeline with Acquisition of Theragnostics Ltd Acquisition of next generation radiopharmaceutical clinical pipeline to include Auger-based systemic targeted PARP inhibitor radiation therapiesExpansion of operations in the USAcquisition of commercial FDA-approved, diagnostic product...